CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focusing on higher-growth precision testing and digital solutions.
The transaction, approved by both companies’ boards, is expected to close by the end of the third quarter of 2026.
• CareDx stock is at critical resistance. Why is CDNA stock breaking out?
Strategic Shift Toward Core Testing Services
John Hanna, pres… [2080 chars]
Source: Benzinga | Published: 2026-04-16T18:37:19Z
Credit: Benzinga
